Diet-gene interactions in human lipoprotein metabolism

Journal of the American College of Nutrition

Volumn 16, Issue 4, 1997, Pages 313-324

  Dreon, Darlene M ^a   Krauss, Ronald M ^b  

^a CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

Coronary disease; Diet; Genetics; Lipoproteins

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A4; APOLIPOPROTEIN B; APOLIPOPROTEIN C3; APOLIPOPROTEIN E; CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR;

ALLELE; CORONARY ARTERY DISEASE; DIET THERAPY; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; HYPERCHOLESTEROLEMIA; LIPOPROTEIN METABOLISM; LOW FAT DIET; REVIEW;

APOLIPOPROTEINS; CHOLESTEROL, DIETARY; DIET; FEMALE; HUMANS; LIPOPROTEINS; LIPOPROTEINS, LDL; MALE; VARIATION (GENETICS);

ANIMALIA;

EID: 0030800365     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.1997.10718692     Document Type: Article

References (146)

1. Grundy SM, Denke MA: Dietary influences on serum lipids in lipoproteins. J Lipid Res 31: 1149-1172, 1990.
2. Mahley RW: Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240:622-630, 1988.
3. Sing CF, Davignon J: Role of the apolipoprotein E polymorphism in detennining normal plasma lipid and lipoprotein variation. Am J Hum Genet 37:268-285, 1985.
4. Eto M, Watanabe K, Ishii K: Reciprocal effects and apolipoprotein E alleles (E2 and E4) on plasma lipid levels in nonnolipidemic subjects. Clin Genet 29:477-484, 1986.
5. Utermann G: Apolipoprotein E polymorphism in health and disease. AmHeart J 113:433-440, 1987.
6. Boerwinkle E, Visvikis S, Welsh D, Steinmetz J, Hanash SM, Sing CF: The use of measured genotype information in the analysis of quantitative phenotypes in man. II. The role of the apolipoprotein E polymorphism in determining levels, variability, and covariability of cholesterol, betalipoprotein, and triglycerides in a sample ofunrelated individuals. Am J Med Genet 27:567-582, 1987.
7. Boerwinkle E, Utennann G: Simultaneous effects of the apolipoprotein E polymorphism on apolopoprotein E, apolipoprotein B, and cholesterol metabolism. Am J Hum Genet 42: 104-112, 1988.
8. Davignon J, Gregg RE, Sing CF: Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 8:1-21, 1988.
9. Kobori S, Nakamura N, Uzawa H, Shichiri M: Influence of apolipoprotein E polymorphism on plasma lipid and apolipoprotein levels, and clinical chamcteristics of type III hyperlipoproteinemia due to apolipoprotein E phenotype E212 in Japan. Atherosclerosis 69:81-88, 1988.
10. Eichner JE, Kuller LH, Ferrell RE, Kamboh MI: Phenotypic effects of apolipoprotein structural variation on lipid profiles. IV. Apolipoprotein polymorphism in a small group of black women from healthy women study. Genet Epidemio 16:681-689, 1989.
11. Eichner JE, Kuller LH, Ferrell RE, Meilabn EN, Kamboh MI: Phenotypic effects of apolipoprotein structural variation on lipid profiles. III. Contribution of apolipoprotein E phenotype to prediction of total cholesterol, apolipoprotein B, and low density lipoprotein cholesterol in the healthy women study. Arteriosclerosis 10:379-385, 1990.
12. Xu CF, Boerwinkle E, Tikkanen MJ, Huttunen JK, Humphries SE, Talmud PI: Genetic variation at the apolipoprotein gene loci contribute to response of plasma lipids to dietary change. Genet Epidemiol 7:261-275, 1990.
13. Shriver MD, Boerwinkle E, Hewett-Emmett D, Hanis CL: Frequency and effects of apolipoprotein E polymorphism in Mexican-AmericanNIDDM subjects. Diabetes 40:334-337, 1991.
14. Xhignesse M, Lussier-Cacan S, Sing CF, Kessling AM, Davignon J: Influences ofcommon variants of apolipoprotein E on measures of lipid metabolism in a sample selected for health. ArteriosclerThmmb 11:1100-1110, 1991.
15. Dallongeville J, Lassier-Cacan S, Davignon J: Modulation of plasma triglyceride levels by apoE phenotype: A meta-analysis. J Lipid Res 33:447-454, 1992.
16. Schaefer EJ, Lamon-Fava S, Johnson S, Ordovas JM, Schaefer MM, Castelli WP, Wilson PWF: Effects of gender and menopause status on the association ofapolipoprotein E phenotype with plasma lipoprotein levels: results from the Framingham offspring study. Arterioscler Thmmb 14:1105-1113, 1994.
17. Reilly SL, Ferrell RE, Sing CF: The gender-specific apolipoprotein E genotype influence on the distribution of plasma lipids and apolipoproteins in the population of Rochester, MN: III. Correlations and covariances. AmJ Hum Genet 55:1001-1018, 1994.
18. Miller NE: Associations of high -density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis. Am Heart J 113:589-597, 1987.
19. Hixson JE: Apolipoprotein E polymorphisms affect atherosclerosis in young males: pathobiological determinants of atherosclerosis in youth (pDAY) research group. Arterioscler Thmmb 11:1237-1244, 1991.
20. Eichner JE, Kuller LH, Orchard RR, Grandits GA, McCallum LM, Ferrell RE, Neaton JD: Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease. Am J Cardio 171:160-165, 1993.
21. de Knijff P, Menzel H-J, Ehnholm C, Nicaud V, Havekes L: ApoE polymorphism and redisposition to coronary heart disease in youths of different european populations. The EARS study. ArteriosclerThmmb 14:1617-1624, 1994.
22. Luc G, Bard J-M, Arveiler D, Evans A, Carnbou J-P, Bingham A, Amouyel P, Schaffer P, Ruidavets J-B, Cambien F, Fruchart J•C, Ducimetiere P: Impact of apolipoprotein E polymorphism on lipo-proteins and risk of myocardial infarction: The ECTIM Study. ArteriosclerThromb 14:1412-1419, 1994.
23. Stengard JH, Zerba KE, Pekkanen I, Ehnholm C, Nissinen A, Sing CF: Apolipoprotein E polymorphism predicts death from coronary heartdisease in a longitudinal study ofelderly Finnish men. Circulation 91:265-269, 1995.
24. Pairitz G, Davignon I, Mailloux H, Sing CF: Sources ofinlerindividual variation in the quantitative levels of apolipoprotein B in pedigrees ascertained through a lipid clinic. Am I Hum Genet 43:311-321, 1988.
25. Smit M, De Knijff P, Rosseneu M, Bury I, Klasen E, Frants R, Havelas L: Apolipoprotein E polymorphism in the Netherlands and its effect on plasma lipid and apolipoprotein levels. Hum Genet 80:287-292, 1988.
26. Eto M, Watanabe K, Chonan N, Ishii K: Familial hypercholesterolemia and apolipoprotein E4. Atherosclerosis 72:123-128, 1988.
27. Kuusi T, Nieminen MS, Ehnholm C, Yki JH, Valle M, Nikkilli EA, Taskinen MR: Apoprotein E polymorphism and coronary artery disease. Increased prevalence ofapolipoprotein E4in angiographically verified coronary patients. Arteriosclerosis 9:237-241, 1989.
28. Dallongeville I, Roy M, Leboeuf N, Xhignesse M, Davignon I, Lussier-Cacan S: Apolipoprotein E polymorphism association with lipoprotein profile in endogenous hypertriglyceridemia and familial hypercholesterolemia. Arteriosclerosis 11:272-278, 1991.
29. Kamboh MI, Sepehmia B, Ferrell RE: Genetic studies of human apolipoproteins VI. Common polymorphism ofapolipoprotein E in blacks. Disease Markers 7:49-55, 1989.
30. Ebnholm C, Lukka M, Kuusi T, Nikkila E, Utrnnann G: Apolipoprotein E polymorphism in the Finnish population: gene frequencies and relation to lipoprotein concentrations. I Lipid Res 27:227-235, 1986.
31. Lehtimaki T, Moilanen T, Vrikari I, Akerblom HI, Ehnholm C, Ronnernaa T, Mamiemi I, Dahlen G, Nikkari T: Apolipoprotein E phenotypes in Finnish youths: a cross-sectional and 6-year followup study. I Lipid Res 31:487-495, 1990.
32. Kuusi T, Taskinen M-R, Solakivi T, Kauppinen-Makelin R: Role of apolipoproteins E and C in type V hyperlipoproteinemia. I Lipid Res 29:293-298, 1988.
33. Miettinen TA, Kesliniemi VA: Cholesterol absorption: regulation of cholesterol synthesis and elimination and within-population variations ofserum cholesterol levels. Am J Clin NUb" 49:629-635, 1989.
34. Tlkkanen MJ, Huttunen IK, Ehnholm C, Pietinen P: Apolipoprotein E4 homozygosity predisposes to serum cholesterol elevation during high-fat diet. Arteriosclerosis 10:285-288, 1990.
35. Manttari M, Koskinen P, Ehnholm C, Huttunen IK, Manninen V: Apolipoprotein E polymorphism influences the serum cholesterol response to dietary intervention. Metabolism 40:217-221, 1991.
36. Lehtimliki T, Moilanen T, Solakivi T, Laippala P, Ehnholm C: Chlesterol-rich diet induced changes in plasma lipids in relation to apolipoprotein E phenotype in healthy students. Ann Med 24:6166, 1992.
37. Miettinen TA, Gylling H, Vanhanen H, Ollus A: Cholesterol absorption, elimination, and synthesis related to LDLkinetics during varying fat intake in men with different apoprotein E phenotypes. ArteriosclerThromb 12:1044-1052, 1992.
38. Cobb MM, Teitlebaum HS, Risch N, Ieke IJI, Ostfeld AM: Influence of dietary fat, apolipoprotein E phenotype, and sex on plasma lipoprotein levels. Circulation 86:849-857, 1992.
39. Lopez-Miranda I, Ordovas JM, Mata P, Lichtenstein AH, Clevidence B, Iudd IT, Schaefer EJ: Effect of apolipoprotein E phenotype on diet-induced lowering of plasma low density lipoprotein choles-terol. I lipid Res 35:1965-1975, 1994.
40. Dreon DM, Fernstrom HA, Miller B, Krauss RM: Apolipoprotein E isoform phenotype and LDL subclass response to a reduced-fat diet. ArteriosclerThromb Vasc Bioi 15:105-111, 1995.
41. Clifton PM, Kestin M, Abbey M, Drysdale M, Nestel PI: Relationship between sensitivity to dietary fat and dietary cholesterol. Arteriosclerosis 10:394-401, 1990.
42. Boerwinkle E, Brown SA, Rohrbach K, Gotto AM Jr., Patsch W: Role of apolipoprotein E and B gene variation in determining response oflipid, lipoprotein, and apolipoprotein levels to increased dietary cholesterol. Am I Hum Genet 49:1145-1154, 1991.
43. Glatz JFC, Demacker PNM, Turner PR, Katan MB: Response of serum cholesterol to dietary cholesterol in relation to apolipoprotein E phenotype. NUb" Metab Cardiovasc Dis 1:13-17, 1991.
44. Savolainen MJ, Rantala M, Kervinen K, Iarvi L, Suvanto K, Rantala T, Kesaniemi VA: Magnitude of dietary effects on plasma cholesterol concentration: Role of sex and apolipoprotein E phenotype. Atherosclerosis 86:145-152, 1991.
45. Cobb MM, Risch N: Low-density lipoprotein cholesterol responsiveness to diet in nonnolipidemic subjects. Metabolism 42:7-13, 1993.
46. Sarltkinen ES, Uusitupa MO, Pietinen P, Am A, Ahola I, Penttila I, Kervinen K, Kesaniemi YA: Long-termeffects ofthree fat-modified diets in hypercholesterolemic subjects. Atherosclerosis 105:9-23, 1994.
47. Zambon D, Ros E, Casals E, Sanllehy C, Bertomeu A, Campero I: Effect of apolipoprotein E polymorphism on the serum lipid response to a hypolipidemic diet rich in monounsaturated fatty acids in patients with hypercholesterolemia and combined hyperlipidemia. AmIClinNub 61:141-148, 1995.
48. Miettinen TA, Gylling H, Vanhanen H: Serum cholesterol response to dietary cholesterol and apoprotein E phenotype. Lancet 2: 1261, 1988.
49. Friedlander Y, Berry EM, Eisenberg S, Stein Y, Leitersdorf E: Plasma lipids andlipoproteins response to a dietary challenge: analysis of four candidate genes. Clin Genet 47: 1-12, 1995.
50. Uusitupa MO, Ruuskanen E, Mlikinen E, Laitinen I, Toskala E, Kervinen K, Kesliniemi VA:A controlled study on the effect ofbetaglucan-rich oat bran on serum lipids in hypercholesterolemic subjects: relation to apolipoprotein E phenotype. I Am Coli NUb" 11:651-659, 1992.
51. Ienkins DJA, Hegele RA, Ienkins AL, Connelly PW, Hallak K, Bracci P, Kashtan H, Corey P, Pintilia M, Stern H, Bruce R: The apolipoprotein E gene and the serum low-density lipoprotein cholesterol response to dietary fiber. Metabolism 42:585-593, 1993.
52. Ehnholm C, Huttunen JK, Pietinen P: Effect of diet on serum lipoproteins in a population with a high risk ofcoronary heart disease. N Engl I Med 307:850-855, 1982.
53. Sepehmia B, Kamboh MI, Adams CL, Bunker CH, Nwankwo M, Majumder PP, Ferrell RE: Genetic studies ofhuman apolipoproteins. X. The effect ofthe apolipoprotein E polymorphism on quantitative levels oflipoproteins in Nigerian blacks. Am J Hum Genet 45 :586-591, 1989.
54. Sepehmia B, Kamboh MI, Adams-Campbell U, Nwankwo M, Ferrell RE: Genetic studies ofhuman apolipoproteins. VII. Population distributionofpolymorphismofapolipoproteinsA-I, A-ll, A-1Y, C-ll, E, and H in Nigeria. Am I Hum Genet 43:847-853, 1988.
55. Weintraub MS, Eisenberg S, Breslow IL: Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E. J Clin Invest 80:1571-1577, 1987.
56. Demant T, Bedford D, Packard CJ, Shepherd J: Influence of apolipoprotein E polymorphism on apolipoprotein B-l00 metabolism in normolipemic subjects. J Clin Invest 88:1490-1501, 1991.
57. Sehayek E, Eisenberg S: Mechanisms ofinhibition by apolipoprotein C of apolipoprotein E-dependent cellular metabolism of human triglyceride-rich lipoproteins through the low density lipoprotein receptor pathway. J Bioi Chern 266:18259-18267, 1991.
58. Gylling H, Miettinen TA: Cholesterol absorption and synthesis related to low density lipoprotein metabolism during varying cholesterol intake in men with different apoE phenotypes. J Lipid Res 33:1361-1371, 1992.
59. Brenninkmeijer BJ, Stuyt PMJ, Demacker PNM, Stalenhoef AFH, vant Laar A: Catabolismof chylomicron remnants in normolipidemic subjects in relation to the apoprotein E phenotype. J Lipid Res 28:361-370, 1987.
60. Brown AJ, Roberts DCK: The effect of fasting triacylglyceride concentration and apolipoprotein E polymorphism on postprandial lipemia. Arteriosc1erThromb 11:1737-1744, 1991.
61. Nikkilii M, Solakivi T, Lehlimiiki T, Koivula T, Laippala P, Astrom B: Postprandial plasma lipoprotein changes in relation to apolipoprotein E phenotypes and low density lipoprotein size in men with and without coronary artery disease. Atherosclerosis 106:149-157, 1994.
62. Gregg RE, Zech LA, Schaefer EJ, Stark D, Wilson D, BrewerHB Jr: Abnormal in vivo metabolism of apolipoprotein E4 in humans. J Clin Invest 78:815-821, 1986.
63. Superko HR, Haskell WL: The effect of apolipoprotein E isoform difference on postprandial lipoprotein composition in patients matched for triglycerides, LDL-cholesterol, andHDL-cholesterol. Artery 18:315-325, 1991.
64. Boerwinlde E, Brown S, Sharrett JR, Heiss G, PatschW:Apolipoprotein E polymorphism influences postprandial retinyl palmitate but not triglyceride concentrations. Am J Hum Genet 54:341-360, 1994.
65. KesSniemi YA, Ehnholm C, Miettinen TA: Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype. J Clin Invest 80:578-581, 1987.
66. Miettinen TA, Vanhanen H: Dietary sitostanol related to absorption, synthesis and serum level of cholesterol in different apolipoprotein E phenotypes. Atherosclerosis 105:217-226, 1994.
67. Weisgraber KH, Innerarity TL, Mahley RW: Abnormal lipoprotein receptor-binding activity of the human apoprotein E due to cysteine-arginine interchange at a single site. J Bioi Chern 257:2518, 1982.
68. Linga V, Leight MA, Curtiss LK, Marcel YL, Clair RW, Parks JS: Dietary fish oil-induced decrease in low density lipoprotein binding to fibroblasts is mediated by apolipoprotein E. J Lipid Res 35:491-500, 1994.
69. Roe RP, Jones PJH, Frohlich JJ: Association between apolipoprotein E phenotype and endogenous cholesterol synthesis as measured by deuterium uptake. Cardiovasc Res 25:249-255, 1991.
70. Palmer RH, Nichols AV, Dell RB, Ramakrishnan R, Lindgren FT, Gong EL, Blum CB, Goodman DS: Lack of relationship in humans of the parameters of body cholesterol metabolism with plasma levels of subfractions of HDLor LDL, or with apoE isoform phenotype. J Lipid Res 27:637-644, 1986.
71. Jones PJH, Main BF, Frohlich JJ: Response ofcholesterol synthesis to cholesterol feeding in men with different apolipoprotein E genotypes. Metabolism 42:1065-1071, 1993.
72. Williams PT, Dreon DM, Krauss RM: Effects ofdietary fat on highdensity lipoprotein subclasses are influenced by both apolipoprotein E isoforms and low-density lipoprotein subclass pattern. Am J Clin Nutr 61 :1234-1240, 1995.
73. Martin U, Connelly PW, Nancoo D, Wood N, Zhang ZJ, Maguire G, Quinet E, Tall AR, Marcel YL, McPherson R: Cholesteryl ester transfer protein and high density lipoprotein responses to cholesterol feeding in men: relationship to apolipoprotein E genotype. J Lipid Res 34:437-446, 1993.
74. Weisgraber KH: Apolipoprotein E distribution among human plasma lipoproteins: role of the cysteine-arginine interchange at residue J Lipid Res 31:1503-1512, 1990.
75. Tozuka M, Hidaka H, Miyachi M, Furihata K, Katsuyama T, Kanai M: Identification and characterization of apolipoprotein(AII-E2AlI) complex in human plasma lipoprotein. Biochim Biophys Acta Lipids Lipid Metab 1165:61-67, 1992.
76. Green PH, Glickman RM, Riley JW, Quinet E: Human apolipoprotein A-IV; intestinal origin and distribution in plasma. J Clin Invest 65:911-919, 1980.
77. Rye KA, Garrety KH, Barter PJ: Changes in the size ofreconstituted high density lipoproteins during incubation with cholesteryl ester transfer protein: The role of apolipoproteins. J Lipid Res 33:215-224, 1992.
78. Steinmetz A, Barbaras R, Ghalim N, Clavey V, Fruchart JC, Ailhaud G: Human apolipoproteinA-IV binds toapolipoproteinA-I1A-Ilreceptor sites and promotes cholesterol efflux from adipose cells. J Bioi Chern 265:7859-7863, 1990.
79. Lohse P, Kindt MR, Rader OJ, Brewer HJ:Genetic polymorphism of human plasma apolipoprotein A-IV is due to nucleotide substitutions in the apolipoprotein A-IV gene. J BioI Chern 265:10061-10064, 1990.
80. Menzel H-J, Boerwinlde E, Schrangl-Will S, Utermann G: Human apolipoprotein A-IV polymorphism: frequency and effect on lipid and lipoprotein levels. Hum Genet 79:368-372, 1988.
81. Menzel HJ, Sigurdsson G, Boerwinlde E, Schrangl WS, Dieplinger H, Utermann G: Frequency and effect of human apolipoproteinA-IV polymorphism on lipid and lipoprotein levels in an Icelandic population. Hum Genet 84:344-346, 1990.
82. de Knijff P, Rosseneu M, Beisiegel U, de Kecrsgieter W, Frants RR, Havekes LM: Apolipoprotein A-IV polymorphism and its effect on plasma lipid and apolipoprotein concentrations. J Lipid Res 29:1621-1627, 1988.
83. Hanis CL, Douglas TC, Hewett-Emmett D: Apolipoprotein A-IV protein polymorphism: Frequency and effects on lipids, lipoproteins, and apolipoproteins among Mexican-Americans in Starr County, Texas. Hum Genet 86:323-325, 1988.
84. Kaprio J, Ferrell RE, Kottke BA, Kamboh MI, Sing CF: Effects of polymorphisms in apolipoproteins E, A-IV, and H on quantitative traits related to risk for cardiovascular disease. ArteriosclerThromb 11:1330-1348, 1991.
85. KbnEckardstein A, Funke H, Schulte M, Erren M, Schulte H, Assmann G: Nonsynonymous polymorphic sites in the apolipoprotein (apo) A-IV gene are associated with changes in the concentration ofapo B-and apo A-I-containing lipoproteins in a normal population. Am J Hum Genet 50:1115-1128, 1992.
86. McCombs RJ, Marcadis DE, Ellis J, Weinberg RB: Attenuated hypercholesterolemic response to a high-cholesterol diet in subjects heterozygous for the apolipoprotein A-IV-2 allele. N Eng J Med 331 :706-710, 1994.
87. Mata P, Ordovas JM, Lopez-Miranda J, Lichtenstein AH, Clevidence B, Judd IT, Schaefer EJ. ApoA-IV phenotype affects diet-induced plasmaLDLcholesterol lowering. ArteriosclerThromb 14:884-891, 1994.
88. Rader OJ, Schafer J, Lohse P, Verges B, Kindt M, Zech LA, Steinmetz A, Brewer HBJ: Rapid in vivo transport andcatabolism of human apolipoprotein A-lV-I and slower catablism of the apo A-IV-2 isoprotein. J Clin Invest 92: 1009-1017, 1993.
89. Weinberg RB, Jordan MK, Steinmetz A: Distinctive structure and function ofhuman apolipoprotein variantApoA-IV-2. J Bioi Chern 265:18372-18378, 1990.
90. Barter P: High density lipoproteins and reverse cholesterol transport. CurrOpin Lipidol 4:210-217, 1993.
91. Lee DM, Dashti N, Mok T: Apolipoprotein B-100 is the major form of this apolipoprotein secreted by human intestinal Caco-2 cells. Biochem Biophys Res Comm 156:581-587, 1988.
92. Mahley RW, Innerarity TL: Lipoprotein receptors and cholesterol homeostasis. Biochim Biophys Acta 737:197-222, 1983.
93. Brown MS, Goldstein JL: A receptor-mediated pathway for cholesterol homeostatis. Science 232:34-47, 1986.
94. Tybj-Hansen A, Nordestgaard BG: Apolipoprotein B genotypes predict atherosclerosis and hyperlipidemia. Circulation 82 Suppl.11:3-621, 1990.
95. Genest JJ, Ordovas JM, McNamara JR, Robbins AM, Meade T, Cohn SD, Salem DN, Wilson P, Masharani U, Frossard PM, Schaefer EJ: DNA polymorphisms of the apolipoprotein B gene in patients with premature coronary artery disease. Atherosclerosis 82:7-17, 1990.
96. Brunzell JD, Sniderman AD, Albers II, Kwiterovich PO Jr: Apoproteins B and A-I and coronary heart disease in humans. Arteriosclerosis 4:79-83, 1984.
97. Ladias JM, Kwiterovich PO Jr., Smith HH, Miller M, Bachorik PS, Forte T, Lusis AJ, Antonarakis SE: Apolipoprotein B-loo Hopkins (arginine4019-tryptophan).A new apolipoprotein B-loo variant in a family with premature atherosclerosis and hyperapobetalipoproteinemia. JAMA 262:1980-1988, 1989.
98. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC, Krauss RM: Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 260:1917-1921, 1988.
99. Crouse JR, Parks JS, Schey HM, Kohl FR: Studies of low density lipoprotein molecular weight in human beings with coronary artery disease. J. Lipid Res 26:566-574, 1985.
100. Aalto-Setala K, TJkkanen MJ, Taskinen MR, Nieminen M, Holmberg P, Kontula K: XbaI and rig polymorphisms of the apolipoprotein B gene locus are associated with serum cholesterol and LDL-cholesterollevels in Finland. Atherosclerosis 74:47-54, 1988.
101. Gylling H, Aalto-Setlilil K, Kontula K, Miettinen TA: Serum low density lipoprotein cholesterol level andcholesterol absorption efficiency are influenced by apolipoprotein B and E polymorphism and by the FH-Helsinki mutation of the low density lipoprotein receptor gene in familial hypercholesterolemia. Arterioscler TIlromb 11:1368-1375, 1991.
102. Houlston RS, Turner PR, Lewis B, Humphries SE: Genetic epidemiology of differences in low-density lipoprotein (LDL) cholesterol concentration: Possible involvement of variation at the apolipoprotein B gene locus in LDLkinetics. Genet Epidemiol 7: 199-210.
103. Berg K: DNApolymorphism at the apolipoprotein B locus is associated with lipoprotein level. Clin Genet 30:515-520, 1986.
104. Law A, Wallis SC, Powell LM, Pease RJ, Brunt H, Priestly LM, Knott TJ, Scott J, Altman OO, Miller GJ, Rajput J, Miller NE: Common DNA polymorphism within coding sequence of apolipoprotein B gene associated with altered lipid levels. Lancet 1:1301-1303, 1986.
105. Talmud PJ, Bami N, Kessling AM, Carlsson P, Damfors C, Bjursell G, Galton D, Wynn V, Kirk H, Hayden MR, Humphries SE: Apolipoprotein B gene variants are involved in the determination of serum cholesterol levels: a study in norm-and hyperlipidemic individuals. Atherosclerosis 67:81-89, 1987.
106. Aalto-Setlilil K, Gylling H, Helve E, Kovanen P, Miettinen TA, Turtola H, Kontula K: Genetic polymorphism ofthe apolipoprotein B gene locus influences serum LDL cholesterol level in familial hypercholesterolemia. Hum Genet 82:305-307, 1989.
107. Hegele RA, Huang L-S, Herbert PN, Blum CB, Buring JB, Hennekens CH, Breslow JL: Apolipoprotein B geneDNApolymorphisms associated with myocardial infarction. N Engl J Med 315:1509-1515, 1986.
108. Aburatani H, Matsumoto A, ltoh H, Yamada N, Murase T, Takaka F, ltakura H: A study ofDNA polymorphism in the apolipoprotein B gene in a Japanese population. Atherosclerosis 72:71-76, 1988.
109. TJkkanen MJ, Xu C-F, HlimliUiinen T, Talmud P, Sarna S, Huttunen JK, Pietinen P, Humphries S: Xbal polymorphism of the apolipoprotein B gene influences plasma lipid response to diet intervention. Clinical Genetics 37:327-334, 1990.
110. Talmud PJ, BoerwinIde E, Xu C, Tikkanen MJ, Pietinen P, Huttunen JK, Humphries S: Dietary intake andgene variation influence the response of plasma lipids to dietary intervention. Genet Epidemiol 9:249-260, 1992.
111. Abbey M, Belling B, Clifton P, Nestel P: Apolipoprotein B gene polymorphism associates with plasma cholesterol changes induced by dietary fat and cholesterol. Nutr Metab Cardiovasc Dis 1:10-12, 1991.
112. Xu C, Tlkkanen MJ, Huttunen JK, Pietinen P, Biitler R, Humphries S, Talmud P: Apolipoprotein B signal peptide insertion/deletion polymorphism is associated with Ag epitopes and involved in the determination of serum triglyceride levels. J Lipid Res 31:1255-1261, 1990.
113. Hegele RA, Zahariadis G, Jenkins AL, Connelly PW, Kashtan H, Stem H, Bruce R, Jenkins DJA: Genetic variation associated with differences in the response of plasma apolipoprotein B levels to dietary fibre. Clinical Science 85:269-275, 1993.
114. Ilmonen M, Helio T, Butler R, Palotie A, Pietinen P, Huttunen JK, Tikkanen MJ: Two newimmunogenetic polymorphisms of the apo B gene and their effect on serum lipid levels andresponses to changes in dietary fat intake. ArteriosclerTIlromb Vase BioI 15:1287-1293, 1995.
115. Lopez-Miranda J, Ordovas JM, Espino A, Marin C, Salas J, LopezSegura F, Jimenez-Pereperez J, Perez-Jimenez F: Influence of mutation in human apolipoprotein A-I gene promoter on plasma LDL cholesterol response to dietary fat. Lancet 343: 1246-1249, 1994.
116. Boyd NF, Cousins M, Beaton M, Kriukov V, Lockwood G, Tritehler D: Quantitative changes in dietary fat intake and serum cholesterol in women: results from a randomized, controlled trial. Am J Clin Nutr 52:470-476, 1990.
117. Beynen AC, Katan MB: Reproducibility of the variations between humans in the response of serum cholesterol to cessation of egg consumption. Atherosclerosis 57: 19-31, 1985.
118. Kalan MH, Berns MAM, Glatz JFC, Knuiman IT, Nobels A, deVries JHM: Congruence of individual responsiveness to dietery cholesterol and to saturated fat in humans. J Lipid Res 29:883-892, 1988.
119. Keys A: Diet and blood cholesterol in population surveys-lessons from analysis of the data from a major survey in Israel. Am J Clin Nutr 48:1161-1165, 1988.
120. Kestin M, Clifton PM, Rouse lL, Nestel PJ: Effect of dietary cholesterol in normolipidemic subjects is not modified by nature and amount of dietary fat. Am J Clin NUb 50:528-532, 1989.
121. Applebaum-Bowden D, Haffner SM, Hartsook E, Luk KH, Albers JJ, Hazzard WR: Down-regulation of the low-density lipoprotein receptor by dietary cholesterol. Am J Clin NUb 39:360-367, 1984.
122. Meddings M, Dietschy JM: Regulation of plasma levels of lowdensity lipoprotein cholesterol: interpretation of data on low-density lipoprotein turnover in man. Circulation 74:805-814, 1986.
123. Gylling H, Miettinen TA: Absorption and metabolism of cholesterol in familial hypercholesterolaemia. Clin Sci 76:297-301, 1989.
124. McNamara OJ, Kolb R, Parker TS, Batwin H, Samuel P, Brown CD, Ahrens EH lt: Heterogeneity of cholesterol homeostasis in man. J Clin Invest 79: 1729-1739, 1987.
125. Jones PJ, Lichtenstein AH, Schaefer EJ: Interaction of dietary fat saturation and cholesterol level on cholesterol synthesis measured using deuterium incorporation. J Lipid Res 35:1093-1101, 1994.
126. Field FJ, Kant NTP, MathurSN: Regulation ofcholesterol metabolism in the intestine. Gastroenterology 99:539-551, 1990.
127. Safonova IG, Sviridov DD, Roytman A, Rytikov FM, Dolgov VV, Nano JL, Rampal P, Repin VS: Cholesterol uptake in the human intestine. Hypo-and hyperresponsiveness. Biochim Biophys Acta Lipids Lipid Metab 1166:313-316, 1993.
128. Craig WY, Nutik R, Cooper AD: Regulation ofapoprotein synthesis and secretion in the human hepatoma Hep G2. The effect of exogenous lipoprotein. J Bioi Chern 263:13880-13890, 1988.
129. Austin MA, King MC, Vranizan KM, Krauss RM: Atherogenic lipoprotein phenotype: A proposed genetic marker for coronary heart disease risk. Circulation 82:495-506, 1990.
130. Campos H, Genest JJ Jr, Blijlevens E, McNamara JR, Jenner JL, Ordovas JM, Wilson PWF, Schaefer EJ: Low density lipoprotein particle size andcoronary artery disease. ArteriosclerThromb 12:187-195, 1992.
131. Coresh J, Kwiterovich PO Jr, Smith HH, Bachorik PS: Association of plasma triglyceride concentration and LDL particle diameter, density, and chemical composition with premature coronary artery disease in men and women. J Lipid Res 34: 1687-1697, 1993.
132. Austin MA, King MC, Vranizan KM, Newman B, Krauss RM: Inheritance oflow-density lipoprotein subclass patterns: results of complex segregation analysis. Am J Hum Genet 43:838-846, 1988.
133. Austin MA: Genetic epidemiology of low-density lipoprotein subclass phenotypes. Ann Med 24:477-481, 1992.
134. Nishina PM, Johnson JP, Naggert JK, Krauss RM: Linkage ofatherogenic lipoprotein phenotype to the low density lipoprotein receptor locus on the short arm ofchromosome 19. Proc Natl Acad Sci USA 89:708-712, 1992.
135. Rotter JI, Bu X, Cantor R, Warden CH, Brown J, Gray RJ, Blanche PJ, Krauss RM, Lusis AJ: Multilocus genetic determinants ofLDL particle size in coronary artery disease families. Am J Hum Genet 58:585-594, 1996.
136. Austin MA, Newman B, Selby JY, Edwards K, Mayer EJ, Krauss RM: Genetics of LDL subclass phenotypes in women twins: Concordance, heritability, and commingling analysis. ArteriosclerThromb 13:687-695, 1993.
137. Campos H, Willett WC, Peterson RM, Siles X, Bailey SM, Wilson PWF, Posner BM, Ordovas JM, Schaefer EJ: Nutrient intake comparisons between Framingham and rural and urban Puriscal, Costa Rica: Associations with lipoproteins, apolipoproteins, and low density lipoprotein particle size. ArteriosclerThromb 11:1089-1099, 1991.
138. Krauss RM, Dreon DM: Low density lipoprotein subclasses and response to a low-fat diet in healthy men. Am J Clin NUb 62:478S-487S, 1995.
139. Dreon DM, Fernstrom HA, Miller B, Krauss RM: Low-density lipoprotein subclass patterns and lipoprotein response to a reduced-fat diet in men. FASEB J 8:121-126, 1994.
140. Kashyap MJ, Barnhart RL, Srivastava LS, Perisuth G, Vmk P, Allen C, Hogg E, Brady D, Glueck CJ, Jackson RL: Effects of dietary carbohydrate and fat on plasma lipoproteins and apolipoproteins C-I1 and C-lIIin healthy men. J Lipid Res 23:877-886, 1982.
141. Garg A, Bonanome A, Grundy SM, Zhang Z-J, Unger RH: Comparison of a high-carbohydrate diet with a high-monounsaturated fat diet in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 319:829-834, 1988.
142. Fisher WR, Heterogeneity ofplasma low density lipoprotein: Manifestations of the physiologic phenomenon in man. Metabolism 32:283-291, 1983.
143. Deckelbaum RJ, Granot E, Oschry Y, Rose J, Eisenberg S: Plasma triglyceride determines structure-composition in low and high density lipoproteins. Arteriosclerosis 4:225-231, 1984.
144. Vega GJ, Grundy SM: Kinetic heterogeneity of low density lipoproteins in primary hypertriglyceridemia. Arteriosclerosis 6:395-406, 1986.
145. McNamara JR, Jenner JL, Li Z, Wilson PWF, Schaefer EJ: Change in LDL particle size is associated with change in plasma triglyceride concentration. Arterioscler Thromb 12: 1284-1290, 1992.
146. Campos H, Dreon OM, Krauss RM: Associations of hepatic and lipoprotein lipase activities with changes in dietary composition and low density lipoprotein subclasses. J Lipid Res 36:462-472, 1995.